ImmunoMet Therapeutics Email Formats

Biotechnology Research • Houston, Texas, United States • 1-10 Employees

ImmunoMet Therapeutics Email Formats

ImmunoMet Therapeutics uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@immunomet.com), used 66.7% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@immunomet.com	66.7%
{first name}{last name}	johndoe@immunomet.com	33.3%

Key Contacts at ImmunoMet Therapeutics

Benjamin Cowen

Board Director

Dean Welsch

Chief Executive Officer

Tingchen Cui

Co-Chief Executive Officer

Company overview

Headquarters	2450 HOLCOMBE BLVD, Houston, Texas 77021, US
Phone number	+13467720318
Website	immunomet.com
NAICS	541714
SIC	873
Keywords	Fibrosis And Oncology
Founded	2015
Employees	1-10
Socials

About ImmunoMet Therapeutics

ImmunoMet Therapeutics is a clinical stage biotech targeting cellular metabolism to develop novel anti-fibrotic and anti-tumor therapies. Our lead molecule, IM156, is a protein complex 1 (PC1) inhibitor that targets the Oxidative Phosphorylation (OXPHOS) pathway in mitochondria and decreases aberrant cell growth in fibrosis and select cancer cells. IM156 is the first potent PC1 inhibitor to complete Phase 1 with a good tolerability. In fibrosis, ImmunoMet is currently conducting a Phase 1 study in healthy volunteers and plan to progress into Phase 2 PoC study in IPF patients in 4Q2021. The company was founded in 2015, is a spin-off from HanAll Biopharma, a Korean midsized public company, and has raised $31 MM post-spin-off.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Entry

Director

Employees by Department

ImmunoMet Therapeutics has 3 employees across 2 departments.

Departments

Number of employees

Funding Data

Explore ImmunoMet Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-03-08	1	$7,000,000
2021-03-08	5	$7,000,000

Funding Insights

$14,000,000

Total funding amount

$7,000,000

Most recent funding amount

Number of funding rounds

ImmunoMet Therapeutics Tech Stack

Discover the technologies and tools that power ImmunoMet Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

Smart Slider 3

WordPress plugins

Lightbox

JavaScript libraries

PHP

Programming languages

Bluehost

Hosting

Font Awesome

Font scripts

WordPress

Blogs

OceanWP

WordPress themes

MySQL

Databases

Elementor

Page builders

Frequently asked questions

ImmunoMet Therapeutics is located in Houston, Texas, US.

You can reach ImmunoMet Therapeutics at +13467720318.

ImmunoMet Therapeutics was founded in 2015, making it 11 years old. The company has established itself as a significant player in its industry over this time.

ImmunoMet Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

ImmunoMet Therapeutics has raised a total of $14,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.